1 rich Libsyn https://www.libsyn.com 90 600 Dr. Bryan McLaughlin is the president of Micro-Leads, a medical device company working on implantable therapy for spinal cord stimulation. In this episode, he discusses his research and investigation into medical-grade technologies to treat spinal cord injury, as well as his collaboration with DARPA in this endeavor. Top three takeaways: The electrodes manufactured by Micro-Leads used for spinal cord stimulation target more fibers and have more electrode channels than other electrodes McLaughlin is investigating medical-grade electrode technology for spinal cord stimulation that uses flexible materials McLaughlin is collaborating with DARPA as part of their “bridging the gap” program for treatment of spinal cord injury [0:00] Ladan introduces the episode and the guest, Dr. Bryan McLaughlin, at SfN 2019 [1:15] Micro-Leads distinguishes itself from other spinal cord stimulation companies by offering electrodes that reach fibers that couldn’t have been targeted previously, with more electrode channels [4:45] This technology specifically targets pain, which is a major unmet need [6:15] Dr. McLaughlin’s research company has devised medical-grade electrode technology using soft, flexible materials that can be used to help patients with spinal cord injury. [8:50] Dr. McLaughlin discusses collaborating with DARPA to develop technologies for treating spinal cord injury Neural Implant podcast - the people behind Brain-Machine Interface revolutions http://neuralimplantpodcast.com <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/12655475/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/87A93A/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/item/12655475